Results 241 to 250 of about 74,284 (255)

The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma

Annals of Oncology
Joaquim Bellmunt, Lucia Kwak, X X Wei
exaly  

GLYCOENGINEERED ANTIBODY DRUG CONJUGATES

2016
AVILA LUIS Z, ZHOU QUN
openaire   +7 more sources

CKIT ANTIBODY DRUG CONJUGATES

2016
ABRAMS TINYA, COHEN STEVEN BRUCE, DANIEL DYLAN, FINNER CATRIN, GEIERSTANGER BERNHARD HUBERT, HUBER THOMAS, MALLET WILLIAM, MEYER MATTHEW JOHN, OU WEIJIA, SCHLEYER SIEW HO, TISSOT-DAGUETTE KATHRIN ULRIKE   +10 more
openaire   +3 more sources

Antibody-polymer-drug conjugates

2018
YANG JIYUAN, KOPECEK JINDRICH, ZHANG LIBIN, FANG YIXIN   +3 more
openaire   +4 more sources

Multi-drug antibody drug conjugates

2018
openaire   +4 more sources

Antibody-drug conjugates and immunotoxins

2015
KONTERMANN ROLAND, PFIZENMAIER KLAUS, FERRER CRISTINA, FABRE MYRIAM, SIMON LAUREANO   +4 more
openaire   +9 more sources

LINKER FOR ANTIBODY-DRUG CONJUGATES, AND ANTIBODY-DRUG CONJUGATE

MAKI KEISUKE, MIYAJIMA RIN, SHU ZHAOMA, OHDACHI KAZUHIRO, YAMASHITA YU   +4 more
openaire   +1 more source

PSMA ANTIBODY-DRUG CONJUGATES

2007
MA DANGSHE, MADDON PAUL J, OLSON WILLIAM C, DORONINA SVETLANA O, TOKI BRIAN E, SENTER PETER D   +5 more
openaire   +4 more sources

LINKERS FOR ANTIBODY DRUG CONJUGATES

2018
TSUCHIKAMA KYOJI, ANAMI YASUAKI, TSUCHIKAMA CHISATO, ZHANG NINGYAN, AN ZHIQIANG   +4 more
openaire   +6 more sources

Disitamab vedotin, a HER2‐directed antibody‐drug conjugate, in patients with HER2‐overexpression and HER2‐low advanced breast cancer: a phase I/Ib study

Cancer Communications
exaly